Even as the COVID-19 pandemic took hold, Roswell Park Comprehensive Cancer Center scientists continued to draw support for their innovative research proposals, garnering more than $34 million in competitive grants from government agencies and private funders.
These recent grants fund efforts to improve outcomes for patients with some of the most challenging cancer types — including triple-negative breast cancer, pancreatic cancer and head and neck cancers — and to advance what we know about the impact of COVID-19 in cancer patients.
“The scope and significance of the research being conducted right here at Roswell Park Comprehensive Cancer Center cannot be understated,” says Congressman Brian Higgins, co-chairman of the U.S. House of Representatives Cancer Caucus. “The federal government invests in promising science and scientists. The magnitude of these grants represents a confidence in the work Roswell Park does and the hope Roswell Park’s discovery brings to families confronting COVID and cancer.”